EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Predictive Value of NT pro BNP for New-Onset Atrial Fibrillation in Heart Failure and Preserved Ejection Fraction

Xiao Liu, Sixu Chen, Hong Pan, Zenghui Zhang, Yue Wang, Yuan Jiang, Maoxiong Wu, Zhiteng Chen, Ayiguli Abudukeremu, Zhengyu Cao, Qingyuan Gao, Minghai Zhang und 4 weitere

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14951 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Xiao Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Peptide Fragments, Heart Failure, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The prognostic significance of N-terminal pro B-type natriuretic peptide (NT-proBNP) in heart failure with preserved ejection fraction (HFpEF) has been well established. HFpEF and atrial fibrillation (AF) commonly coexist, and each contributes to poor outcomes independently. Nevertheless, the ability of NT-proBNP to predict AF in HFpEF patients remains uncertain. Methods and results A total of 367 HFpEF patients without baseline AF from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial were included. The Cox proportional hazard model was used to assess the association of NT-proBNP with the risk of AF. The C-statistic, categorical net reclassification index (NRI), and integrated discrimination improvement (IDI) were used to evaluate the ability of NT-proBNP in new-onset AF prediction. During a median follow-up of 2.91 years, 17 (4.63%) new-onset AF cases occurred. Every 1000 pg/mL increase in NT-proBNP was associated with a 16% increase in the risk of AF occurrence after adjustments (hazard ratio, 1.16 [95% CI, 1.02–1.32]). NT-proBNP showed a moderate performance for new-onset AF at 3 years (C-statistic, 0.67). Adding NT-proBNP to CHADS2/R2CHADS2/CHA2DS2-VASc/C2HSET scores improved their predictive performance for AF risk (CHADS2: C-statistic, 0.63, CHADS2+NT: C-statistic, 0.69, NRI, 47.46%, IDI, 1.18%; R2CHADS2: C-statistic, 0.65, R2CHADS2+NT: C-statistic, 0.70, NRI, 48.03%, IDI, 0.51%; CHA2DS2-VASc: C-statistic, 0.67, CHA2DS2-VASc+NT: C-statistic, 0.72, NRI, 49.41%, IDI, 0.86%; C2HSET: C-statistic, 0.77, C2HSET+NT: C-statistic, 0.80, NRI, 50.32%, IDI, 1.58%).

Conclusions

Among patients with HFpEF, the NT-proBNP level was positively associated with the incidence of new-onset AF and may be a promising predictor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPeptide FragmentsHeart FailureNatriuretic Peptide, BrainStroke VolumeBiomarkersHumansFemaleMaleAgedPrognosisFollow-Up StudiesPredictive Value of TestsMiddle AgedIncidenceVentricular Function, LeftRisk Assessment

Stichwörter der Autor:innen

Atrial fibrillationHFpEFNT‐proBNPPrediction

Substanzen

pro-brain natriuretic peptide (1-76)Peptide FragmentsNatriuretic Peptide, BrainBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Guangzhou, China.
  • Guangzhou Key Laboratory of Molecular Mechanism and Translation in Major Cardiovascular Disease, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-Sen Memorial Hospital, Foshan, China.
  • Department of Emergency, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Yuling Zhang

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Bureau

Zitieren

APA

Liu, X., Chen, S., Pan, H., Zhang, Z., Wang, Y., Jiang, Y., Wu, M., Chen, Z., Abudukeremu, A., Cao, Z., Gao, Q., Zhang, M., Zhu, W., Chen, Y., Zhang, Y., & Wang, J. (2024). Predictive Value of NT pro BNP for New-Onset Atrial Fibrillation in Heart Failure and Preserved Ejection Fraction. ESC Heart Failure. https://doi.org/10.1002/ehf2.14951

Vancouver

Liu X, Chen S, Pan H, Zhang Z, Wang Y, Jiang Y, et al. Predictive Value of NT pro BNP for New-Onset Atrial Fibrillation in Heart Failure and Preserved Ejection Fraction. ESC Heart Failure. 2024. doi:10.1002/ehf2.14951

BibTeX
@article{Liu2024,
  author = {Liu, Xiao and Chen, Sixu and Pan, Hong and Zhang, Zenghui and Wang, Yue and Jiang, Yuan and Wu, Maoxiong and Chen, Zhiteng and Abudukeremu, Ayiguli and Cao, Zhengyu and Gao, Qingyuan and Zhang, Minghai and Zhu, Wengen and Chen, Yangxin and Zhang, Yuling and Wang, Jingfeng},
  title = {Predictive Value of NT pro BNP for New-Onset Atrial Fibrillation in Heart Failure and Preserved Ejection Fraction},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14951}
}
Kostenlos starten →